Immunonutrition and Neuromonitoring for Postoperative Delirium in Gynecologic Oncology
NCT07877285
Summary
Early postoperative delirium (POD) is a common and distressing neuropsychiatric complication frequently observed in elderly patients undergoing major surgical interventions, including radical and cytoreductive gynecologic oncological procedures (such as ovarian, cervical, and endometrial cancer surgeries). Delirium is associated with prolonged hospital and intensive care unit stays, functional decline, elevated healthcare expenditures, and increased perioperative morbidity. The pathogenesis of postoperative delirium is multifactorial, involving baseline patient vulnerability and intraoperative triggering factors. Malnutrition and systemic inflammation are recognized as critical predisposing factors that disrupt blood-brain barrier integrity and trigger neuroinflammatory cascades. The Controlling Nutritional Status (CONUT) score and the Naples Prognostic Score (NPS) are objective scoring systems combining nutritional biomarkers (serum albumin, total cholesterol) and immune-inflammatory markers (absolute lymphocyte count, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio). Concurrently, intraoperative neuromonitoring (such as processed electroencephalography / bispectral index monitoring) provides continuous assessment of cerebral anesthetic depth and electrophysiological patterns like burst suppression, which have been implicated in acute cerebral dysfunction. The objective of this prospective observational study is to evaluate the individual and combined predictive utility of preoperative immunonutritional indices (CONUT and Naples Prognostic Score) alongside intraoperative neuromonitoring parameters for the occurrence of early postoperative delirium in elderly patients undergoing elective gynecologic oncological surgery.
Eligibility
Inclusion Criteria: 1. Female patients aged 65 years or older. 2. Scheduled for elective major gynecologic oncological surgery (e.g., radical hysterectomy, cytoreductive surgery for ovarian, cervical, or endometrial cancer). 3. American Society of Anesthesiologists (ASA) physical status II-IV. 4. Planned to undergo general anesthesia with continuous intraoperative neuromonitoring / processed EEG. 5. Signed written informed consent provided prior to surgery. Exclusion Criteria: 1. Pre-existing dementia, significant cognitive impairment, or baseline Mini-Mental State Examination (MMSE) score below validated cut-offs. 2. History of major neuropsychiatric disorders, active neurodegenerative disease, or acute cerebrovascular accident within the preceding 6 months. 3. Patients undergoing emergency surgical procedures. 4. Uncorrected severe sensory deficits (auditory or visual impairments) precluding postoperative delirium assessments. 5. Missing preoperative baseline nutritional or hematological laboratory parameters required for CONUT or Naples scoring. 6. Inability to comply with post-anesthesia cognitive evaluations or re-operation required during the observation window.
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07877285